BGM Group Ltd
BGM
View Detailed Chart
4.310USD
-0.090-2.05%
Close 12/23, 16:00（ET）Quotes delayed by 15 min
423.65MMarket Cap
LossP/E TTM
Intraday
1m
30m
1h
D
W
M
D
Today
-2.05%
5 Days
-16.63%
1 Month
-47.18%
6 Months
-67.02%
Year to Date
-48.99%
1 Year
-49.41%
View Detailed Chart
TradingKey Stock Score of BGM Group Ltd
Currency: USD Updated: 2025-10-27Key Insights
Its valuation is considered undervalued, Institutional ownership is very low.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
BGM Group Ltd's Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Analyst Rating
Based on
0
analysts
--
Current Rating
0.000
Target Price
0.00%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
BGM Group Ltd Highlights
StrengthsRisks
BGM Group Ltd, formerly Qilian International Holding Group Ltd, is a company mainly engaged in the development, manufacture, marketing and sale of licorice products, oxytetracycline products, traditional Chinese medicine derivatives (TCMD) product, heparin product, sausage casings and fertilizers. The Company operates through three segments: Oxytetracycline & Licorice Products and TCMD segment, Fertilizer segment and Heparin Products and Sausage Casing segment. The Company's main brand is Qilian Shan. The Company principally operates its businesses within the domestic market.
Growing
The company is in a growing phase, with the latest annual income totaling USD 25.10M.
Overvalued
The company’s latest PE is -32.82, at a high 3-year percentile range.
Institutional Buying
The latest institutional holdings are 132.27K shares, increasing 18.83% quarter-over-quarter.
Held by James Simons
Star Investor James Simons holds 29.97K shares of this stock.
BGM Group Ltd News
More news coming soon, stay tuned...
Financial Indicators
EPS
Relevant data have not been disclosed by the company yet.
Total revenue
Relevant data have not been disclosed by the company yet.
BGM Group Ltd Info
BGM Group Ltd, formerly Qilian International Holding Group Ltd, is a company mainly engaged in the development, manufacture, marketing and sale of licorice products, oxytetracycline products, traditional Chinese medicine derivatives (TCMD) product, heparin product, sausage casings and fertilizers. The Company operates through three segments: Oxytetracycline & Licorice Products and TCMD segment, Fertilizer segment and Heparin Products and Sausage Casing segment. The Company's main brand is Qilian Shan. The Company principally operates its businesses within the domestic market.
Ticker SymbolBGM
CompanyBGM Group Ltd
CEOXin (Zhanchang)
Websitehttps://www.bgmgroupltd.com/
FAQs
What is the current price of BGM Group Ltd (BGM)?
The current price of BGM Group Ltd (BGM) is 4.310.
What is the symbol of BGM Group Ltd?
The ticker symbol of BGM Group Ltd is BGM.
What is the 52-week high of BGM Group Ltd?
The 52-week high of BGM Group Ltd is 17.170.
What is the 52-week low of BGM Group Ltd?
The 52-week low of BGM Group Ltd is 4.360.
What is the market capitalization of BGM Group Ltd?
The market capitalization of BGM Group Ltd is 423.65M.
What is the net income of BGM Group Ltd?
The net income of BGM Group Ltd is -1.44M.
Is BGM Group Ltd (BGM) currently rated as Buy, Hold, or Sell?
According to analysts, BGM Group Ltd (BGM) has an overall rating of --, with a price target of --.
What is the Earnings Per Share (EPS TTM) of BGM Group Ltd (BGM)?
The Earnings Per Share (EPS TTM) of BGM Group Ltd (BGM) is -0.285.
Related Instruments
-0.47%
-0.75%
+0.38%
+0.64%
+1.64%
+0.32%
+0.03%
+7.32%
+0.83%
-1.31%
+0.60%
-0.24%
-0.71%
+0.88%
+0.50%
+1.55%
+0.75%
0.00%
-0.19%
-2.21%
